A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin.

Source:http://linkedlifedata.com/resource/pubmed/id/15018740

Download in:

View as

General Info

PMID
15018740